Dynamic Technology Lab Private LTD Castle Biosciences Inc Transaction History

Dynamic Technology Lab Private LTD

  • $601 Million
  • Q4 2024

A detailed history of Dynamic Technology Lab Private LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 17,630 shares of CSTL stock, worth $461,024. This represents 0.08% of its overall portfolio holdings.

Number of Shares
17,630
Previous 43,894 59.84%
Holding current value
$461,024
Previous $1.25 Million 62.51%
% of portfolio
0.08%
Previous 0.14%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$26.52 - $34.67 $696,521 - $910,572
-26,264 Reduced 59.84%
17,630 $469,000
Q3 2024

Nov 12, 2024
BUY
$17.4 - $31.47 $763,755 - $1.38 Million
43,894 New
43,894 $1.25 Million
Q1 2022

May 16, 2022
SELL
$33.17 - $46.98 $288,910 - $409,195
-8,710 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $340,212 - $588,621
8,710 New
8,710 $373,000
Q3 2021

Nov 15, 2021
SELL
$60.13 - $77.6 $188,808 - $243,663
-3,140 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$50.07 - $76.78 $157,219 - $241,089
3,140 New
3,140 $230,000
Q4 2020

Feb 11, 2021
SELL
$43.6 - $73.05 $199,295 - $333,911
-4,571 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$38.47 - $52.03 $175,846 - $237,829
4,571 New
4,571 $235,000
Q2 2020

Aug 14, 2020
SELL
$27.28 - $43.01 $308,591 - $486,529
-11,312 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$23.08 - $35.53 $261,080 - $401,915
11,312 New
11,312 $337,000

Others Institutions Holding CSTL

# of Institutions
210
Shares Held
26.6M
Call Options Held
128K
Put Options Held
35.4K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $688M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email